NASDAQ OMX

Crown Bioscience Showcases Dramatic Proficiency in PDX Models and Emerging Expertise in Immune-Oncology

Dela

Post AACR Immuno-Oncology Scientific Advancements

SANTA CLARA, Calif., June 01, 2017 (GLOBE NEWSWIRE) -- Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE: ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology and metabolic disease research, announces depth and breadth of technologies that ignite and accelerate the development of new immune-oncology drug discovery.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/71dfadf0-8256-43cd-bafb-c429a8d37457

CrownBio scientific contribution to AACR:

  • Technology which engrafts human immune cells into immunocompromised animals. When tested with immune activating agents, both short-term (PBMC) and long-term (CD34+ stem cell) engraftment strategies demonstrate robust anticancer activity. 

  • Syngeneic models - both in vitro and in vivo data utilizing their MuScreen(TM) platform, a large panel of well-characterized and validated syngeneic models, employed to test the activity of immune modulating anticancer drugs.

  • Utilization of RNASeq data providing expression and mutation data from 18 cell lines. Investigators leverage this data to test both targeted therapy and immune-modulatory therapy in combination, thus providing rationale for clinical investigation.

  • In vivo, the MuScreen platform enables an agnostic investigation of a compound's activity and mechanism of action. MuScreen data can be followed-up with additional pharmacology studies, such as immunophenotyping, or bioluminescent assessment of metastatic burden.

"Our diligent focus on innovation, and continued scientific advancement charter unprecedented discovery in our immuno-oncology portfolio," said Jean-Pierre Wery, CEO of CrownBio. "The robust contribution at this year's annual meeting of the American Association for Cancer Research, on the part of our scientific team, validates an unwavering commitment to develop therapies that will impact the way cancer is treated."

CrownBio can be located at ASCO Booth #17071. To schedule a meeting with our scientific leadership visit: https://www.crownbio.com/asco-meeting-req

For more information on CrownBio's commitment to furthering the field of oncology and metabolic disease drug discovery, visit https://www.crownbio.com.

About Crown Bioscience Inc.

Crown Bioscience is a global drug discovery and development solutions company providing translational platforms to advance oncology and metabolic disease research. With an extensive portfolio of relevant models and predictive tools, Crown Bioscience enables clients to deliver superior clinical candidates.

Media Enquiries:
Jody Barbeau
Crown Bioscience Inc. marketing@crownbio.com



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Crown Bioscience Inc. via Globenewswire

Om

NASDAQ OMX
NASDAQ OMX



Följ NASDAQ OMX

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från NASDAQ OMX

BIMobject AB: Correction: BIMobject among fastest growing tech companies in EMEA18.12.2017 15:47Pressmeddelande

BIMobject comes in at place 185 in an objective ranking of the 500 fastest growing tech companies in Europe, the Middle East, and Africa. In a corresponding ranking of Swedish companies, BIMobject places 24 th out of 50.  The Deloitte Technology Fast 500(TM) EMEA programme is an objective industry ranking that compares and lists the fastest growing technology companies in Europe, the Middle East, and Africa during the past four years. The 2017 winners were selected based on percentage fiscal-year revenue growth from 2013 to 2016. The regional ranking Sweden Technology Fast 50 lists the fastest growing companies in the Swedish tech industry.  "Our places in the Deloitte rankings are great news proving that our expansion strategy works. The BIMobject Cloud is now the world's leading platform for digital building products. That's the kind of innovation that drives us while we keep working towards growth", says Stef

BIMobject AB: Rättelse: BIMobject bland de snabbast växande techbolagen i EMEA18.12.2017 15:47Pressmeddelande

BIMobject hamnar på plats 185 i objektiv rankning av de 500 snabbast växande techföretagen i Europa, Mellanöstern och Afrika. I motsvarande rankning av svenska företag tilldelas BIMobject plats 24 av 50.  Programmet Deloitte Technology Fast 500(TM) EMEA är en objektiv branschrankning som jämför och listar de snabbast växande techföretagen i Europa, Mellanöstern och Afrika under de senaste fyra åren. Vinnarna för år 2017 valdes ut baserat på procentandelen inkomsttillväxt under räkenskapsåren 2013 till 2016. Den regionala rankningen Sweden Technology Fast 50 listar de snabbast växande företagen inom den svenska techbranschen.  "Våra placeringar i Deloittes rankningar är jätteroliga nyheter som visar att vår strategi för expansion håller. Molnlösningen BIMobject Cloud är nu världens ledande plattform för digitala byggobjekt. Det är sådan innovation vi drivs av samtidigt som vi fortsätter hålla siktet inställt på tillväxt", säger Stefan Larsson, VD och gru

BIMobject AB: BIMobject bland de snabbast växande techbolagen i EMEA18.12.2017 15:18Pressmeddelande

BIMobject hamnar på plats 158 i objektiv rankning av de 500 snabbast växande techföretagen i Europa, Mellanöstern och Afrika. I motsvarande rankning av svenska företag tilldelas BIMobject plats 24 av 50.  Programmet Deloitte Technology Fast 500(TM) EMEA är en objektiv branschrankning som jämför och listar de snabbast växande techföretagen i Europa, Mellanöstern och Afrika under de senaste fyra åren. Vinnarna för år 2017valdes ut baserat på procentandelen inkomsttillväxt under räkenskapsåren 2013 till 2016. Den regionala rankningen Sweden Technology Fast 50 listar de snabbast växande företagen inom den svenska techbranschen.  "Våra placeringar i Deloittes rankningar är jätteroliga nyheter som visar att vår strategi för expansion håller. Molnlösningen BIMobject Cloud är nu världens ledande plattform för digitala byggobjekt. Det är sådan innovation vi drivs av samtidigt som vi fortsätter hålla siktet inställt på tillväxt", säger Stefan Larsson, VD och grun

BIMobject AB: BIMobject among fastest growing tech companies in EMEA18.12.2017 15:18Pressmeddelande

BIMobject comes in at place 158 in an objective ranking of the 500 fastest growing tech companies in Europe, the Middle East, and Africa. In a corresponding ranking of Swedish companies, BIMobject places 24 th out of 50.  The Deloitte Technology Fast 500(TM) EMEA programme is an objective industry ranking that compares and lists the fastest growing technology companies in Europe, the Middle East, and Africa during the past four years. The 2017 winners were selected based on percentage fiscal-year revenue growth from 2013 to 2016. The regional ranking Sweden Technology Fast 50 lists the fastest growing companies in the Swedish tech industry.  "Our places in the Deloitte rankings are great news proving that our expansion strategy works. The BIMobject Cloud is now the world's leading platform for digital building products. That's the kind of innovation that drives us while we keep working towards growth", says Stef

SD-WAN Market Leader, Aryaka, Releases First EMEA Edition of its State of SD-WAN Connectivity Report18.12.2017 15:06Pressmeddelande

Research finds up to 20x cloud and SaaS application performance improvements when connecting via private network-based SD-WANs versus the public Internet LONDON, Dec. 18, 2017 (GLOBE NEWSWIRE) -- Aryaka®, the leading global SD-WAN provider, has released its first EMEA Edition of the State of SD-WAN Connectivity report that analyses the performance of SD-WAN deployments over the Internet as compared with those delivered over global private networks. The report highlights specific application response times between various European, Middle East, Asia-Pacific and Americas locations, as well as key factors that impact the performance of cloud and SaaS applications. This research helps IT leaders in Europe, Middle East and Africa (EMEA) to evaluate the best underlying connectivity for their SD-WAN deployments to ensure fast, reliable and consistent performance for all on-premises, cloud and SaaS applications, including voice, video, and data. The report reveals significant dif

Navigators to Acquire Belgian Specialty Insurer18.12.2017 07:30Pressmeddelande

STAMFORD, CT, December 18, 2017 - The Navigators Group, Inc. (NASDAQ:NAVG) today announced that it has entered into a share purchase agreement for the purchase of all of the shares of Assurances Continentales - Continentale Verzekeringen NV ("ASCO") and Bracht, Deckers & Mackelbert NV ("BDM").  ASCO and BDM are both based in Antwerp, Belgium. The proposed acquisition is part of Navigators' strategy of expanding its well-established specialty insurance expertise to more brokers and insureds across Europe. ASCO is a specialty insurance company offering marine and property and casualty insurance. BDM is an insurance underwriting agency that underwrites risk coverage in niche markets on behalf of ASCO and a number of major international insurers. Additionally, as part of the transaction, Navigators will acquire all the shares of Canal Re SA, a Luxembourg reinsurance company that is a wholly-owned subsidiary of ASCO.  The acquisition reinforces Navigators' presence in the European Un

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum